Sort   by:  
 Page size 
TranscriptomicsStromal contribution to expression signatures of colorectal cancer (CRC tumor)
We noticed that a recently identified poor prognosis stem/serrated molecular subtype of colorectal cancer (CRC) is characterized by up-regulation of transcripts known to be also expressed by stromal cells. To better define the origin of such transcripts, we analyzed RNAseq and microarray datasets f...
ORGANISM(S): Mus musculus 
2014-05-01 | E-GEOD-56695 | biostudies-arrayexpress
TranscriptomicsEpigenetic profiles of CRC-derived samples by scGET-seq
Multiple samples of Patient Derived Xenografts (PDX) of a EGFR-resistant colorectal cancer are recovered at different times and profiled by scGET-seq.
ORGANISM(S): Homo sapiens 
2021-08-17 | E-MTAB-9659 | biostudies-arrayexpress
GenomicsThe Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
Colorectal cancer (CRC) is the third most common cancer world-wide with 1.2 million patients diagnosed yearly. In late stage CRC, the most commonly used targeted therapies are monoclonal antibodies cetuximab and panitumumab, which inactivate EGFR. Recent studies have identified alterations in KRAS...
EGAS00001001305 | EGA
Genomicsena-DATASET-JHUSM-28-09-2015-22:11:53:244-560 - samples
Description not provided
EGAD00001001628 | EGA
Genomicsena-DATASET-JHUSM-16-11-2015-19:53:19:325-4 - samples
Description not provided
EGAD00001001674 | EGA
GenomicsDAC for the study of response to EGFR Blockade in Colorectal Cancer
Data Access Committee EGAC00001000360
EGAC00001000360 | EGA
Sort   by:  
 Page size